We further conducted a loss-of-function analysis to confirm that cPLA2 is the molecular target of pyruvate, by ablating cPLA2 globally in mice and inducing HFD obesity. This evidence concerns the gene PLA2G4A and obesity due to melanocortin 4 receptor deficiency.